192 related articles for article (PubMed ID: 23018179)
1. Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.
Abaan OD; Hendriks W; Uren A; Toretsky JA; Erkizan HV
Exp Cell Res; 2013 Jan; 319(1):1-11. PubMed ID: 23018179
[TBL] [Abstract][Full Text] [Related]
2. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.
Abaan OD; Levenson A; Khan O; Furth PA; Uren A; Toretsky JA
Oncogene; 2005 Apr; 24(16):2715-22. PubMed ID: 15782144
[TBL] [Abstract][Full Text] [Related]
3. Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1.
Zhang SH; Liu J; Kobayashi R; Tonks NK
J Biol Chem; 1999 Jun; 274(25):17806-12. PubMed ID: 10364224
[TBL] [Abstract][Full Text] [Related]
4. Valosin-containing protein (VCP)-Adaptor Interactions are Exceptionally Dynamic and Subject to Differential Modulation by a VCP Inhibitor.
Xue L; Blythe EE; Freiberger EC; Mamrosh JL; Hebert AS; Reitsma JM; Hess S; Coon JJ; Deshaies RJ
Mol Cell Proteomics; 2016 Sep; 15(9):2970-86. PubMed ID: 27406709
[TBL] [Abstract][Full Text] [Related]
5. PTPN13/PTPL1: an important regulator of tumor aggressiveness.
Freiss G; Chalbos D
Anticancer Agents Med Chem; 2011 Jan; 11(1):78-88. PubMed ID: 21235435
[TBL] [Abstract][Full Text] [Related]
6. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A.
Ohama T; Brautigan DL
J Biol Chem; 2010 Mar; 285(12):8711-8. PubMed ID: 20100830
[TBL] [Abstract][Full Text] [Related]
8. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
[TBL] [Abstract][Full Text] [Related]
9. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
10. PTPL1: a large phosphatase with a split personality.
Abaan OD; Toretsky JA
Cancer Metastasis Rev; 2008 Jun; 27(2):205-14. PubMed ID: 18265946
[TBL] [Abstract][Full Text] [Related]
11. Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin.
He J; Zhu Q; Wani G; Sharma N; Wani AA
J Biol Chem; 2016 Apr; 291(14):7396-408. PubMed ID: 26826127
[TBL] [Abstract][Full Text] [Related]
12. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
Bertram C; von Neuhoff N; Skawran B; Steinemann D; Schlegelberger B; Hass R
BMC Cell Biol; 2008 Feb; 9():12. PubMed ID: 18279508
[TBL] [Abstract][Full Text] [Related]
13. COP9 signalosome interacts ATP-dependently with p97/valosin-containing protein (VCP) and controls the ubiquitination status of proteins bound to p97/VCP.
Cayli S; Klug J; Chapiro J; Fröhlich S; Krasteva G; Orel L; Meinhardt A
J Biol Chem; 2009 Dec; 284(50):34944-53. PubMed ID: 19826004
[TBL] [Abstract][Full Text] [Related]
14. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein.
He J; Zhu Q; Wani G; Wani AA
Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256
[TBL] [Abstract][Full Text] [Related]
15. The immunoexpression of valosin-containing protein and small VCP-interacting protein in rat ovaries.
Kartal B; Alimoğulları E; Çaylı S
Anat Histol Embryol; 2023 Jul; 52(4):546-551. PubMed ID: 36843060
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of valosin-containing protein, a protein tyrosine kinase substrate in hematopoietic cells.
Egerton M; Samelson LE
J Biol Chem; 1994 Apr; 269(15):11435-41. PubMed ID: 8157674
[TBL] [Abstract][Full Text] [Related]
17. Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
Laço MN; Cortes L; Travis SM; Paulson HL; Rego AC
PLoS One; 2012; 7(9):e43563. PubMed ID: 22970133
[TBL] [Abstract][Full Text] [Related]
18. AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization.
Hauler F; Mallery DL; McEwan WA; Bidgood SR; James LC
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19733-8. PubMed ID: 23091005
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
[TBL] [Abstract][Full Text] [Related]
20. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]